Prohibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence. Within two years, we have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier. We firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis. Our research and content teams routinely share the latest legislative developments and ... (view full description)

Prohibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.
Within two years, we have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier.
We firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis.
Our research and content teams routinely share the latest legislative developments and key trends in the industry - information that is regularly cited by political leaders, investment banks and Fortune 500 companies.
Our consultancy team works with investors, operators and regulators to identify and execute opportunities across multiple jurisdictions. We advise our private clients on licensing, regulatory and business opportunities.
Winchester MD is one of the fastest growing Cannabis companies in the UK with an already established leading sales channel and ever expanding product range. The rapid growth of the CBD and THC based products industry is an enormous opportunity. Winchester has begun an ambitious expansion program to ensure we can meet the increasing demand for high quality CBD and THC products.
Abacus Health Products is a publicly traded company in Toronto (CSE:ABCS) engaged in the development and commercialization of over-the-counter (OTC), FDA-registered, topical medications which contain organic and natural ingredients, including CBD. The Abacus products are aimed at the rapidly growing markets for topical pain relief and skin care and are based on proprietary, patent-pending technologies developed by Abacus. Abacus' formulations combine FDA-approved active pharmaceutical ingred ... (view full description)

Abacus Health Products is a publicly traded company in Toronto (CSE:ABCS) engaged in the development and commercialization of over-the-counter (OTC), FDA-registered, topical medications which contain organic and natural ingredients, including CBD. The Abacus products are aimed at the rapidly growing markets for topical pain relief and skin care and are based on proprietary, patent-pending technologies developed by Abacus. Abacus' formulations combine FDA-approved active pharmaceutical ingredients with CBD for specific medical indications such as pain relief, acne, and eczema.
Cowen and Company, the broker-dealer business of Cowen Inc. (Nasdaq:COWN), provides industry focused investment banking for growth-oriented companies, domain knowledge-driven research services and a robust sales and trading platform to companies and institutional investor clients. Sectors of focus for the business include healthcare, technology, consumer, industrials, aerospace and defense and energy. Founded in 1918, Cowen is headquartered in New York and has offices worldwide.
Eco Equity is a UK based medicinal cannabis company that holds a government licence to grow, cultivate and export medicinal cannabis and its derivatives from Zimbabwe into Europe. Managing Directors Mr Jon Paul Doran and Mr Timothy Ambrose have a wealth of experience in Financial, Media and Entrepreneurial backgrounds and are driving the company to its mission of being the biggest distributor of medicinal cannabis from Zimbabwe into the EU. With an impressive 350 hectares of land we are working ... (view full description)

Eco Equity is a UK based medicinal cannabis company that holds a government licence to grow, cultivate and export medicinal cannabis and its derivatives from Zimbabwe into Europe. Managing Directors Mr Jon Paul Doran and Mr Timothy Ambrose have a wealth of experience in Financial, Media and Entrepreneurial backgrounds and are driving the company to its mission of being the biggest distributor of medicinal cannabis from Zimbabwe into the EU. With an impressive 350 hectares of land we are working hard to produce a top quality product at a wholesale scale to generate a natural cure to life threatening illnesses. With this we are committed to delivering on our promise to early investors of paying out dividends by the end of 2019.
Grupo Flor is a leading vertically integrated cannabis company with operations in California and Colombia. Grupo Flor manages 1.5 million square feet of cannabis operations, operates greenhouse and indoor cultivation sites, manufactures oil and finished good products at scale, runs a leading state-wide distribution company, and owns two retail brands (East of Eden and WhiteFire). Grupo Flor understands how to do business in California because it touches every aspect of the industry. They have ... (view full description)

Grupo Flor is a leading vertically integrated cannabis company with operations in California and Colombia. Grupo Flor manages 1.5 million square feet of cannabis operations, operates greenhouse and indoor cultivation sites, manufactures oil and finished good products at scale, runs a leading state-wide distribution company, and owns two retail brands (East of Eden and WhiteFire). Grupo Flor understands how to do business in California because it touches every aspect of the industry. They have developed a leading Private Label program working with many of the top brands in California cannabis. In Colombia, Grupo Flor is poised to be a leader in CBD cultivation and oil production for global export. With 85 unique strains developed specifically for the environment, Grupo Flor will push the envelope in low cost production to create a stable supply chain for leading brands around the world.
Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry. Halo has expertise in all major cannabis manufacturing processes, leveraging proprietary processes and products, and has produced over 4MM grams of oils and concentrates since inception. The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience. Th ... (view full description)

Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry. Halo has expertise in all major cannabis manufacturing processes, leveraging proprietary processes and products, and has produced over 4MM grams of oils and concentrates since inception. The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience. The Company is currently operating in California and Oregon as well as Nevada with our partner Just Quality. The Company has also begun operations in Lesotho Africa through the acquisition of Bophelo Bioscience, creating a gateway into the European markets. With a consumer-centric focus, Halo will continue to market innovative branded and private label products across multiple product categories.
Our mission is to bring safe and relevant products to people who use cannabis as part of a healthy fulfilling lifestyle. Sustainably produced and responsibly made, our products are credibly designed around our mantra: Value, Wellbeing, Credibility, Precision. We believe that “High standards are a way of life”. We are here to bring a meaningful mindset to life with cannabis.”
Multiverse Capital™ provides the most experienced team in the global cannabis venture space. Managing Directors Nic Easley and Skip Sanzeri have worked on over 300 cannabis projects in 13 countries and 30 U.S. states and continue to operationally assist 20-40 new companies per quarter via 3C Consulting, LLC™, the leading global cannabis consulting firm. This experience is fundamental for our Limited Partners since we have deep, hands-on experience in all sectors and regions of the gl ... (view full description)

Multiverse Capital™ provides the most experienced team in the global cannabis venture space. Managing Directors Nic Easley and Skip Sanzeri have worked on over 300 cannabis projects in 13 countries and 30 U.S. states and continue to operationally assist 20-40 new companies per quarter via 3C Consulting, LLC™, the leading global cannabis consulting firm. This experience is fundamental for our Limited Partners since we have deep, hands-on experience in all sectors and regions of the global cannabis industry. Our domestic and international funds are divided into ancillary, medicinal, and recreational cannabis sectors in order to provide diversity for our Limited Partners via plant-touching or ancillary investment opportunities. We compartmentalized each fund to reflect the structure of cannabis regulations around the world, thus helping to manage fund risk.
TenX is Unique: Active, hands on early stage funding and advisory services in: Blockchain, AI, SaaS, Fintech, Cannabis, & Space We run the fund raise process and raise all the $ needed (private, public, equity, debt, token) We are experts with deep operating experience in scaling sales and marketing with > $10B in exits We pay for ourselves many times over, while producing top tier returns for investors
The lawyers at Zuber Lawler & Del Duca exemplify the spirit of our emerging global culture and its demanding substance. With clients all over the world, and attorneys with expertise in the laws of numerous foreign territories, ours is truly an international practice. We have attorneys dually trained in both common and civil law systems, with the corresponding seasoning in cultural insight and languages, including Armenian, Chinese, Farsi, French, German, Italian, Japanese, Korean, Portuguese, ... (view full description)

The lawyers at Zuber Lawler & Del Duca exemplify the spirit of our emerging global culture and its demanding substance. With clients all over the world, and attorneys with expertise in the laws of numerous foreign territories, ours is truly an international practice. We have attorneys dually trained in both common and civil law systems, with the corresponding seasoning in cultural insight and languages, including Armenian, Chinese, Farsi, French, German, Italian, Japanese, Korean, Portuguese, Russian, Spanish, and Taiwanese, among others.
Cannex's proven large-scale cultivation and manufacturing leadership combined with 4Front's retail platform, business development and executive team will create a multi-state vertically integrated powerhouse. The combined entity will represent a new standard for operational excellence and integrity under one umbrella within the cannabis industry. The resulting company will encompass proven management and operational skills in large-scale indoor cultivation facilities that boast industry ... (view full description)

Cannex's proven large-scale cultivation and manufacturing leadership combined with 4Front's retail platform, business development and executive team will create a multi-state vertically integrated powerhouse. The combined entity will represent a new standard for operational excellence and integrity under one umbrella within the cannabis industry.
The resulting company will encompass proven management and operational skills in large-scale indoor cultivation facilities that boast industry-leading yields, the manufacturing and branding of infused products, edibles and other derivative products, and proven experience managing curated customer-centric retail operations.
Chrystal Capital is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices (SFOs), Ultra High Net Worth Individuals (UHNWIs) and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives. For SFOs and UHNWI, we add value by offering unique investment opportunities and the ability to invest alongside like-minded private capital and ex ... (view full description)

Chrystal Capital is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices (SFOs), Ultra High Net Worth Individuals (UHNWIs) and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives. For SFOs and UHNWI, we add value by offering unique investment opportunities and the ability to invest alongside like-minded private capital and experienced institutional investors. For institutional investors, our global network of SFOs and UHNWIs offers wider distribution and provides access to quality capital. For companies seeking funding, we open up additional investor options, including much sought-after and hard-to-reach SFO capital.
Israel's first pure play cannabis enterprise. Isracann, Israel's first pure play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. We're targeting an under supplied domestic market and international markets via exports under Israel's new framework for medical cannabis exports for 2020. Israel's climate lends itself to ultra low cost production of medical cannabis on the doorstep of Europe.
medcann is a Canadian registered company with its roots firmly in Colombia, is dedicated to a long-term strategy to be a fully integrated medicinal cannabis company. We have a particular focus on therapeutic solutions to improve quality of life on a wide range of conditions. We believe this pathway starts early with our agricultural and production approach and driven by our industry leading experts. This is driven by a robust R&D strategy and supporting education and training for health-rel ... (view full description)

medcann is a Canadian registered company with its roots firmly in Colombia, is dedicated to a long-term strategy to be a fully integrated medicinal cannabis company.
We have a particular focus on therapeutic solutions to improve quality of life on a wide range of conditions. We believe this pathway starts early with our agricultural and production approach and driven by our industry leading experts. This is driven by a robust R&D strategy and supporting education and training for health-related professionals. We believe there is a need to ensure patients have access to the right treatments with a quality product and clear guidelines for the use of cannabinoid products.
We recognize our duty to the social and economic improvements we can bring to the cultivation region in Colombia. We are also fully committed to compliance ensuring at each stage we are in line with regulatory and legal requirements and supporting industry wide efforts to correctly position these agents in the range of treatments for pain and other therapeutic targets.
Salveo Capital is a private investment fund focused on the legal cannabis sector. The Fund is based in Chicago, IL and was formed to invest in emerging growth companies within the cannabis sector which include ancillary service providers as well as "plant-touching" businesses. Ancillary sectors of interest include: software & data; financial payments & services; ag-tech; biotech & pharma; business services; and branding & licensing. In addition, the fund is focused on cultivatio ... (view full description)

Salveo Capital is a private investment fund focused on the legal cannabis sector. The Fund is based in Chicago, IL and was formed to invest in emerging growth companies within the cannabis sector which include ancillary service providers as well as "plant-touching" businesses. Ancillary sectors of interest include: software & data; financial payments & services; ag-tech; biotech & pharma; business services; and branding & licensing. In addition, the fund is focused on cultivation, processing, infused products, and other “touch the plant” opportunities. International opportunities outside of the US and Canada will be considered on a select basis. The Fund will invest opportunistically across stage, sector, geography, and structure, and looks to build a long-term partnership with its portfolio companies and its founders.
The Fund is managed by Kief Capital Management LLC, with Managing Partners and the Fund principals bring 45+ years of senior management experience across Wall Street, fund management, and building companies to significant success. The Team is further strengthened by its advisory board and extended network which provides significant experience across cannabis cultivation, agricultural production, energy efficiency, legal & regulatory, data security, pharma, and branding & marketing across CPG and alcohol.
Founded in 2010, The Arcview Group is the first and largest group of investors dedicated to the legal cannabis industry. Since inception, 1200+ dues-paying accredited investors have placed $160+ million behind 170+ companies that have come through the network. Companies such as Eaze, Tokyo Smoke, Mjardin, SPARC, Mirth, Flowhub, Leaf, Wurk, Meadow, Medicine Man, The Goodship, Steep Hill, Growcentia, and many others raised capital from the group. Arcview Market Research publishes the most oft-cit ... (view full description)

Founded in 2010, The Arcview Group is the first and largest group of investors dedicated to the legal cannabis industry. Since inception, 1200+ dues-paying accredited investors have placed $160+ million behind 170+ companies that have come through the network. Companies such as Eaze, Tokyo Smoke, Mjardin, SPARC, Mirth, Flowhub, Leaf, Wurk, Meadow, Medicine Man, The Goodship, Steep Hill, Growcentia, and many others raised capital from the group.
Arcview Market Research publishes the most oft-cited data and analysis on the sector and is regularly quoted in the New York Times, Wall Street Journal, Los Angeles Times, Fortune Magazine and almost every other major media outlet.
Arcview is a partner in Canopy, the first and leading seed-stage mentor-driven business accelerator, which has invested in more than 75 companies. Arcview also co-founded Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry. Forbes Magazine named Arcview among the top 5 financial firms in the cannabis sector.
An undeniable global interest in the study of cannabis treatments inspired the creation of the International Cannabis and Cannabinoids Institute (ICCI), the first Center of Excellence in this field located in the heart of Europe - Czech Republic. ICCI identifies, coordinates and supports global research priorities for the advancement of cannabis and cannabinoid treatments through a multidisciplinary, eviden ... (view full description)

An undeniable global interest in the study of cannabis treatments inspired the creation of the International Cannabis and Cannabinoids Institute (ICCI), the first Center of Excellence in this field located in the heart of Europe - Czech Republic. ICCI identifies, coordinates and supports global research priorities for the advancement of cannabis and cannabinoid treatments through a multidisciplinary, evidence-based approach that incorporates innovative tools and methods.
A collaborative project of non-profit, for-profi t and government institutions, ICCI is an international research and educational hub designed to meet the needs of the global market. ICCI offers an array of services that includes CRO services, agricultural sciences, product development, product safety certification, and government relations. ICCI founders share combined experience that includes:
Clinical and basic research Direct patient advocacy Legislative efforts and studies Government relations Advisory and administration Medical informatics The creation of product safety protocols such as quality control/quality assurance standards and laboratory analysis for the cultivation Manufacturing and distribution of cannabis products and global entrepreneurshipADVFN (www.advfn.com) is a global stocks, shares and crypto information website providing market-leading financial tools and data to private investors around the world. Offering real-time share prices, news feeds, charting, portfolio management, monitor lists, financials, data from global stock exchanges, Level 2 and the most active financial bulletin board in the UK (along with many other features), the site is the destination of choice for day traders and retail investors. Established in the ... (view full description)

ADVFN (www.advfn.com) is a global stocks, shares and crypto information website providing market-leading financial tools and data to private investors around the world.
Offering real-time share prices, news feeds, charting, portfolio management, monitor lists, financials, data from global stock exchanges, Level 2 and the most active financial bulletin board in the UK (along with many other features), the site is the destination of choice for day traders and retail investors.
Established in the last quarter of 1999, ADVFN (LSE:AFN) was floated on the London Stock Exchange’s AIM market in March 2000. The site currently has approximately 36 million users worldwide and a billion page impressions a year.
Originally a UK-based site, the company currently operates in the US (as InvestorsHub.com ) UK, Brazil, Japan and Dubai. ADVFN has a joint venture in Brazil, a country in which ADVFN has a geographic and language targeted website. This is in addition to its US, French, German, Italian, Canadian, Japanese, Indian, Mexican and Filipino ADVFN financial sites.
2019 marks the 50th anniversary of the launch of Euromoney magazine. Since it was founded to cover the growth of cross-border finance, Euromoney has been there to cover every advance, and every challenge, along the way. Today Euromoney’s global portfolio spans websites and magazines, conferences and awards, research and training services. We pride ourselves on our ability to provide unrivalled insights into the people and institutions driving banking, finance and capital markets forward. ... (view full description)

2019 marks the 50th anniversary of the launch of Euromoney magazine. Since it was founded to cover the growth of cross-border finance, Euromoney has been there to cover every advance, and every challenge, along the way. Today Euromoney’s global portfolio spans websites and magazines, conferences and awards, research and training services.
We pride ourselves on our ability to provide unrivalled insights into the people and institutions driving banking, finance and capital markets forward. Our journalists' understanding of what brings success in banking makes our annual Awards for Excellence the most frequently-referenced recognition in banking and our benchmark surveys in core business areas such as foreign exchange, private banking and cash management are recognised as the most important rankings in the industry.
At Green Table, our goal is relatively simple: to elevate and mainstream the conversations and interactions within the cannabis industry. We host premium dinner events where we bring together influencers, investors and experts to exchange ideas, support and resources. We take pride in forging material results for our guests.
Infuzes is the largest cannabis industry database with company profiles, events and conferences, an integrated smart tracker, and global analytics as a resource for cannabis professionals offering essential insights, also giving institutional and retail investors access to real-time, high-quality, reliable market and pricing data.
InvestorsHub.com, an independently operated, USA-based subsidiary of ADVFN PLC, is a leading online investment community website in the North American market. Investor appetite for cannabis-related stocks is extensive on iHub and continuing to accelerate; a high proportion of the site's boards are devoted to discussion about cannabis investment. iHub currently has 713,366 members who have posted 149,159,481 messages on 31,071 boards. Our members currently write ... (view full description)

InvestorsHub.com, an independently operated, USA-based subsidiary of ADVFN PLC, is a leading online investment community website in the North American market. Investor appetite for cannabis-related stocks is extensive on iHub and continuing to accelerate; a high proportion of the site's boards are devoted to discussion about cannabis investment. iHub currently has 713,366 members who have posted 149,159,481 messages on 31,071 boards. Our members currently write on average 40,000 new messages each trading day. The site has 1.3 million users, 5.2 million sessions and 58 million page views per month.
As the most established business information resource for the medical marijuana and retail cannabis industry, Marijuana Business Daily’s editors bring dispensaries, professional cultivators, edibles and infused product makers, ancillary services and suppliers and finance professionals the information and networking they need to flourish. Recent recognition and awards include Trade Show Executive’s Fastest 50, The Inc. 500 and Folio Magazine’s Women in Media.
TERMS AND CONDITIONS OF USE
Below are the terms and conditions governing your use of Euromoney USA LLC ("IMN") this website and any products or services connected therewith. By using the website or services connected with the website, you acknowledge and agree to the following:*Your Obligations. You represent and warrant that you have the capacity to agree to these Terms and you are at least eighteen (18) years of age. To the extent any individual accesses a Site or uses a Service as an employee, partner, director, agent or representative ("Agent") of any legal entity which is a Subscriber, the Agent warrants that he or she has authority to agree to these Terms on behalf of the relevant legal entity.
You will procure that you and any licensed user under your subscription will: (a) comply with all applicable laws in relation to the site and services, including without limitation, laws relating to the use of Intellectual Property; (b) not use the site or the content outside the scope of permitted use and will not infringe any Intellectual Property or other rights in or relating to the site or the services or of any third party; (c) not copy, reproduce, recompile, decompile, disassemble, reverse engineer, upload, download, transmit, create derivative works from or otherwise exploit or tamper with the site or any software embodied in any site or service; (d) not prevent or restrict the use of any site or service by other authorized users nor hack into or cause damage to any server or other equipment operated by us; and (e) comply fully with these Terms.
*No IMN Warranties or Representations. IMN makes no warranty, express or implied, concerning any use of this website or any service or product provided in connection with this website. The services and products provided by IMN are provided on an "AS IS" basis. IMN disclaims any implied warranty of merchantability or fitness for a particular purpose, including any warranty for the use or the results of the use of the products or services. IMN is not responsible for correcting, maintaining or updating the data and services made available on this website.
Any material and analysis provided by or through IMN or this website is not a recommendation that must be followed or an offer, or solicitation of an offer to buy or sell any financial product; IMN does not recommend that you enter into a particular transaction or represent that any product or service described on this website is suitable for you or your company. Nor is any information displayed here promoting any particular financial product, service or trading strategy in any jurisdiction where such an offer or solicitation, or trading strategy may be prohibited. As all prudent investors know, some transactions, including but without limitation, those involving high-yield securities, give rise to substantial risk and any investment decision you may make is your own. You should not enter into any transactions unless you have fully understood all such risks and have independently determined that such transactions are appropriate for you. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or complete discussion of the risks mentioned.
*Restricted Use. As a user of this website, you are not permitted to display, modify, copy, print or otherwise use the information made available to you here only for your own use. You are not permitted to publish, transmit, or otherwise make this information available in any format to any third party without the prior express written consent of IMN. You also are not permitted to change or remove any copyright (©), trademark (®, SM, TM) any other notices displayed with the information. IMN can modify the information at any time and for any reason at its sole discretion. Unless expressly stated otherwise herein, no rights are granted to you regarding the information on this website from IMN or any other source, including third party providers of information for this website, which shall under no circumstances be liable to you in any way.
*IMN Monitoring. Your use of the products and services on this Web site may be monitored by IMN in any lawful manner, and that the resulting information may be used by IMN for its internal business purposes or in accordance with the rules of any applicable regulatory or self-regulatory organization.
*Website or Internet failure. IMN shall have no liability, contingent or otherwise, to you or to third parties, or any responsibility whatsoever, for the failure of any connection or communication service to provide or maintain your access to this service, or for any interruption or disruption of such access or any erroneous communication between IMN and you. IMN also does not warrant or represent that the website shall be completely secure, specifically including without limitation, that no unauthorized person shall intercept or access information transmitted by you.
*Website Access. Access to this website is restricted by password and only authorized IMN registrants may use the website. Any unauthorized access shall be the responsibility of the Registrant and his or her company and IMN shall not be liable for any damages arising out of such unauthorized access. You agree to: (1) Keep your password confidential; (2) prohibit others from using your account; (3) refrain from using other Users’ accounts; (4) refrain from selling, trading, or otherwise transferring your account to another party; and (5) refrain from charging anyone for access to any portion of DirectConnect, or any information arising therefrom. You are also responsible for anything that happens through your account unless you can demonstrate that your account was accessed without your knowledge or fault.
*User Communication. To the extent permitted while using DirectConnect, you can use and participate in groups, free to post and delete comment on the website. You are solely responsible for your interactions with other users. IMN may limit the number of connections you may have to other users and may at its sole discretion prohibit you from contacting other users through use of the Services or otherwise limit your use of the Services.
If you violate this Agreement while posting, that content may be removed without further notice or the rights of others posting here. Nothing you post here is confidential or proprietary and you are cautioned that other posters or viewers may use any information posted here. By posting here you agree that IMN is not responsible for the misappropriation or misuse of any information posted on this website.
*Privacy. Any submissions, including private personal information, like names, addresses and so on, are voluntary and you waive any and all rights you have to the protection of that information. By submitting ideas, suggestions, documents or other matter ("Submissions"), you agree that: (a) the Submissions are not confidential or proprietary information; (b) IMN has no obligation to keep the submissions confidential; (c) IMN can use or disclose the Submissions for any purpose, in any way, in any media worldwide; (d) if asked, you will irrevocably assign to IMN all rights to your Submissions; and (f) you are not entitled to any compensation of any kind from IMN under any circumstances.
*Content by Becoming a User of DirectConnect: As part of obtaining registration access to DirectConnect, unless you opt out, you may receive invitations to network from other conference attendees. We may also send you emails to keep you updated on developments in the site and services. Your registration for and/or subscription to such an email service and your use of the content received through these email services will be subject to these terms. You can unsubscribe to our email service by changing your email preferences on the website.
*License. If you comply with all your obligations under this Agreement, IMN grants you a limited, revocable, nonexclusive license and right to access the Services, through a generally available web browser, mobile device or application view information and use the web pages and in accordance with this Agreement for your use only. Any other use of DirectConnect is strictly prohibited. All rights not expressly granted in this Agreement, including, without limitation, title, ownership, intellectual property rights, and all other rights are retained by IMN.
*Anti-Hacking. You expressly agree not to use or attempt to use any "virus," "spyware," "malware," "adware," "Trojan horse" "deep-link," "scraper," "bot," "spider," "data-mining," "computer code" or any other automated device, program, tool, algorithm, process, or methodology or manual process having similar processes or functionality, to access, acquire, copy, or monitor any portion of this website or content. You also agree not to obtain or attempt to obtain through any means any materials or information on the website that have not been intentionally made available either by their public display on the Web Site or through their accessibility by a visible link or portal. You further agree not to violate the security of the website or attempt to gain unauthorized access to the website, data, materials, information, computer systems or networks connected to any server, through hacking, password mining or any other method.
*No Linkage. You expressly agree not to link or attempt to link to this website or the web pages contained herein.
*Third Party Information. Some of the information you access here is the property of third parties, made available here with the express permission of those third parties. IMN is not responsible for the content of any third party information provided on this website. You are cautioned that any further use of that information by you may be subject to the rights of those third parties and you may be required to obtain a license to use any such information. Failure to obtain third party permission may be a violation of federal law. You should contact the third party provider of the information to ascertain the requirements for using the information.
*Copyright and Trademarks. The layout of the website pages, graphics and pictures used and the collection of individual contributions are protected by copyright. All copyrights belong either to IMN, the third-party content providers or both. Either IMN or the third-party content providers own all trademarks and service marks depicted here.
*Indemnification. You agree to indemnify hold harmless and defend IMN, including our employees, officers, agents and contractors and our related entities and their employees, officers, partners, agents and contractors ("Indemnified") and continue to keep the Indemnified indemnified from and against any actions, proceedings, claims, demands, costs (on a full indemnity basis including, without limitation, reasonable legal and accounting fees) brought or made against the Indemnified by any person arising in connection with your use of the Website or content, or a breach of your representations and warranties in the Terms and Conditions of Use or this Agreement, or your violation of any of the Terms and Conditions of Use or this Agreement or any other activity in which you engage on or through, and from and against any damage, loss(whether personal or property, and whether direct or consequential, including without limitation consequential financial loss), cost or expense suffered or incurred by any Indemnified as a direct or indirect consequence thereof.
*Changes in Terms and Conditions. IMN may at any time revise the terms and conditions by which you may access the website or use IMN products or services. By using this website and IMN products and services, you agree to be bound by any such revisions and should therefore periodically visit this page to determine the then current version of this document.
*Limitation of Liability. Neither we, nor any of our suppliers, officers, employees, partners, affiliates, subsidiaries, successors and assigns, agents or representatives (our "Representatives") will be liable to you for:
(a) any incidental, punitive, indirect, special or consequential damage, loss or expenses, including but not limited to any loss of business, contracts, revenue, or profits, any business interruption, security breach, loss of data, loss of goodwill or reputation or other pecuniary loss suffered by you, even if we or any of our Representatives have been advised of their possible existence; nor? (b) any direct damage loss or expenses arising from loss of customers, loss of profits, loss of anticipated profits or loss of savings.
*Termination. You may terminate this Agreement, for any or no reason, at any time, when IMN receives notice from you. IMN may terminate the Agreement and your account for any reason or no reason, at any time, with or without notice. This cancellation shall be effective immediately or as may be specified in the notice and may include disabling your current and future access to DirectConnect. IMN may also suspend or terminate this Agreement if you invite other users with whom you do not know to connect; abuse the any DirectConnect messaging services; creating multiple or false profiles; infringe on any intellectual property rights, violating any provisions in this Agreement, disparage IMN or its executives, Board members, affiliates, staff or other related entities or persons, or exhibit any other behavior that IMN, in its sole discretion, deems contrary to the purpose of the website.
*No Waiver. Failure by either party to exercise any right or remedy under these Terms does not constitute a waiver of that right or remedy.
*Entire Agreement. These terms (including any terms incorporated by reference in these terms), constitute the entire agreement between you and us with respect to your access to and use of the website or receipt of any service and supersede all prior agreements, negotiations and discussions between you and us relating to the same.
*Law and Jurisdiction. Where you visit, register and/or subscribe to a this site or related service (as indicated on this website or otherwise notified to you), these terms (and any dispute or claim arising out of or in connection with these terms, including non-contractual disputes or claims), to the maximum extent permissible under the law of the territory that you are located in, will be governed by the laws of the State of New York. Any action to enforce these terms shall be brought in a federal court or a state court located in the state of New York, county of New York, and you agree to submit yourself to the personal jurisdiction of those courts in any such action.
*Force Majeure. We shall not be deemed to be in breach of these Terms by reason of any delay in performing, or any failure to perform any service or our obligations in relation to these Terms, if the delay or failure was due to any cause beyond our reasonable control, including but not limited to acts of God, explosions, floods, fire or accident, war or threat of war, terrorism or threat of terrorism, sabotage, civil disturbance, epidemics, prohibitions or measures of any kind on the part of any governmental, parliamentary or local authority, import or export regulations or embargoes, or industrial actions or trade disputes (whether involving our employees or of third parties).
*Severability. If any provision of these Terms is found to be wholly or partially invalid, void or unenforceable by any court having competent jurisdiction or by virtue of any legislation or any other reason, that provision shall be invalid, void or unenforceable to that extent only and no further and the validity and enforceability of the remaining provisions of these Terms shall not be affected.
*Notices. Any notice given pursuant to these Terms shall be made by email or first class post, in the case of you, to the address provided on your registration form and, in the case of us, to the address posted on the website or otherwise notified to you in relation to any relevant service. Any such notice shall be deemed to have arrived if sent by post within three (3) days of posting and if sent by email at the time of transmission.
Euromoney Institutional Investor PLC (“Euromoney”, “we”, “us” or “our”) is an international business-information group covering asset management, price discovery, data and market intelligence, and banking and finance. The group also runs an extensive portfolio of events for the telecoms, financial and commodities markets.
For a full list of our brands and group companies, please click on this link. Euromoney and its group companies are committed to respecting the privacy of every person who visits, registers with or subscribes to our websites, publications, events and other products or services.
Euromoney is the primary data controller of personal data collected through this website or that we may collect in different ways as described in this Privacy Notice. If you are contacted by our other group companies, they will also be controllers of your personal data. This means that they are responsible for how your personal data is used, just as we are. You may contact any of these companies directly, or you can contact Euromoney by emailing dataprotectionofficer@euromoneyplc.com or writing to the Data Protection Officer at Euromoney Institutional Investor PLC, 8 Bouverie Street, London EC4Y 8AX, United Kingdom.
This Privacy Notice was updated on 23 May 2018
This Privacy Notice outlines the information we may collect about you in relation to your use of our products and services (“personal data”). It also explains the legal rights that you have in relation to your data and how you may exercise these rights.
Some of our group companies may collect and use personal data for different purposes; those companies have their own websites and privacy notices.
We will process your data for the following lawful purposes: with your consent; to fulfil our obligations to you; and where there is a legitimate interest to do so.
When possible, we rely on your consent to use your data for the purposes described in this Privacy Notice. We also process personal data to fulfil our contractual obligations to you, for example, when you register for any of our services, subscribe to a publication, sign-up for an event or purchase a product from us, we will need to process some of your personal data. This will also include details of the person/people responsible for payment (if different).
We may determine that processing your personal data serves both of our legitimate interests. This is the case in relation to many of our research, customer survey, sales, marketing and advertising activities described in this Privacy Notice. These activities allow us to better understand your requirements, which in turn enables us to provide you with a better service. We review the bases for our processing decisions carefully and you can object to these activities at any time (see the “Your Rights” section of this Privacy Notice).
Our primary goal in collecting personal data from you is to give you a relevant customised experience of our products and services.
-
Registration, Free Trials & Subscriptions
When you register with our website and/or sign up for a free trial of our products or services, we may ask you to provide your name, address, email address and telephone number, and details relevant to your occupation or employer.
If you subscribe to one of our products or services, we will also ask for payment details. Credit/debit card payments are processed using a third party supplier and we do not retain the credit card data (see the Third Party Sites of this Privacy Notice). Address details may be shared with third party service providers engaged by us for order fulfilment, delivery and payment collection. This personal data is used by us to complete subscription requests.
-
Events & Conferences
If you have registered for an event through a group website we may collect personal data including: name, job title, company, address, telephone number and email.
This information is necessary so that we can complete your registration for the event and provide you with relevant event materials.
We may also provide delegate details (e.g. name, email) to event sponsors who, subject to your consent, may contact you for their own advertising and marketing purposes.
-
Advertising & Marketing
We use the personal data you provide us and which we collect from you to inform you about similar products and services which we provide. We may send you marketing communications that are sponsored by our partners and which are targeted to your interests based on information you have provided us such as job title, employer and/or industry. If you have consented to receive information from other Euromoney group companies, we may share your personal data with these companies so that they can fulfil your request to receive marketing materials in accordance with your preferences. We will not share your personal data with any third parties for their own marketing purposes unless you have provided your consent.
Each of the Euromoney group companies that may contact you is a data controller in relation to the personal data that you have agreed to share with them. If you have any questions or concerns, you may contact the individual company, or us – using the contact details set out in the “Who We Are” section.
You can opt out from receiving such materials at any time.
The personal data we may use for advertising and marketing purposes includes your name, email address, job title, phone number, company name/employer, geo location, postal address and data collected using cookies and other similar technology (Please read our separate Cookies Policy to find out more about which cookies we use, how they work and how you can control your cookie options).
Marketing materials are sent electronically, by post and we may occasionally call you.
-
Online Targeted Advertising
We use targeted advertising on our websites to display advertisements that are relevant to what we believe are your interests. In order to deliver relevant advertisements, we use third parties to deliver cookies that collect information about your IP address and how you interact with our sites (e.g. browsing information, which articles you have read etc.). This data is used by the third parties to determine which advertisements may be of interest to you.
We may also share your personal data with third parties to deliver targeted advertising to you on other websites (e.g. Twitter Tailored Audiences or Facebook Custom Audiences). This could include your email address, cookie data, and information obtained from third parties. Third party cookies may also be used to enable us to target advertisements to you on other websites that you visit.
-
Lead Generation and Scoring
We occasionally use the services of trusted third parties in order to ensure that the personal data we use for advertising and marketing purposes is accurate and up-to-date. To do this, we transfer personal data of individual leads (such as name, email, job title, location and phone number) to these third parties who conduct research to verify the data – primarily against public information.
We also use algorithmic software technology to help us improve the quality and relevance of marketing activities. The personal data analysed by the software includes email address, phone number, job title, address, purchase history and account information. This allows us to provide meaningful offers that are relevant to your specific profile.
-
Surveys, Market Research & Customer Feedback
We want to understand the needs of our readers and customers. We may therefore use the information you provide us – including your name and contact details – to contact you to request your feedback, or to participate in our customer and market research.
-
Public forums, message boards and blogs
Some of the pages on our group websites may include message boards, blogs or other facilities for generating content from users. Any information that is disclosed in these areas becomes public information and you should always be careful when deciding to post any personal data. User generated content is also subject to our site Terms & Conditions.
-
Business or Asset Sale
If we sell a business or assets we may need to disclose your personal data to the prospective buyer of such business or assets.
If Euromoney, or any of our group companies is sold or sells our assets or is acquired by a third party, then personal data about our customers will be acquired by that third party. A transfer of your personal data in these circumstances would be necessary so that the services you have contracted for can still be delivered, or so that you can continue to enjoy the benefits of our free products and services. You will receive notice if a new controller assumes responsibility for your personal data.
-
Additional Third Party Disclosures
We may disclose your personal data to other third parties in the following situations:
- To third party partners who help us by providing services such as technology, marketing, advisory or other services. These third parties only receive encrypted data and may only process personal data to provide those services to us.
- Where we are required by law or regulation to do so. In each case we will seek, where practicable, to minimise the amount of data that is disclosed.
- If required to protect the rights and interests of other users and/or Euromoney and its affiliates (including our employees, agents and contractors), or as otherwise set out in our Terms & Conditions. This may include exchanging information with other companies and organisations for the purposes of fraud protection.
-
Email Tracking
We may include small pixel tags (small image files) within the emails we send you in order to determine whether our emails are opened and/or whether the hyperlinks inside our emails are clicked through. We may also collect browser, location and the device used to engage with our email communications. This information allows us to better understand whether we are meeting our users’ needs and how we can improve our communications. No other information is collected. You can opt out of receiving our direct marketing emails either by following the instructions in each email, or by contacting us (see the “Who We Are” section of this Privacy Notice).
Some of the Euromoney group companies are based outside the European Economic Area (EEA). If you have consented to being contacted by our group companies, then the transfer of your personal data will be made according to the terms of an international data sharing agreement that contains obligations approved by European data protection regulators. Any of our group companies that receive your personal data will be co-controllers of that data, which means they may determine how they process your personal data – although they may only use it for the purposes for which it was shared, unless you are informed of new or additional processing activities.
We may also transfer personal data to third party service providers as described in this Privacy Notice which are located outside the EEA. Where we conduct these transfers, we take all steps necessary to ensure that your data is treated securely and in accordance with applicable privacy legislation, either by only sending your personal data to jurisdictions that provide an adequate degree of legal protection for your data or by imposing approved contractual terms on these third parties.
We have a data retention policy that ensures we don’t use or store your personal data for longer than necessary. We consider the following issues to determine retention periods:
- Guidance from the UK Information Commissioner or other regulatory agency, or industry best practice recommendations;
- The business rationale for collection and expiry of the purpose for which personal data was collected;
- Our ongoing ability to ensure the accuracy of the data; and
- Legal and regulatory requirements.
We may occasionally need to keep personal data for either shorter or longer periods than specified in our retention policy. In such circumstances, application of the retention period to the data will be temporarily suspended. The suspension of an applicable retention period will be carried out in a manner that respects the rights and interests of all persons concerned.
You can use our Preference Centre to select the topics that are of interest to you so that we can send you publications and information about our products and services that are especially relevant to you. You can also choose the channels we use to contact you (email, phone, post, etc.) and can also opt-out of receiving marketing communications.
You have certain rights in relation to your personal data which include the following:
-
Access & Portability
You may request access to any personal data of yours for which Euromoney is responsible as controller. Unless there are legal or regulatory reasons for not doing so, we will confirm whether we process any of your personal data and if we do, we will provide you with the following information: the purposes of the processing, the categories of personal data, any recipients of your personal data, the applicable retention period and the data source. Copies of your personal data will be made available to you in a structured, machine-readable format.
You may also request that we transfer the personal data that you have submitted to us, to another controller, where it is technically feasible for us to do so.
If you have consented to our processing of your personal data, or if we are processing your personal data in order to fulfil our contractual obligations to you, then you can submit a request that we transfer your personal data to another data controller.
-
Rectification, Restriction, Objection
You have the right to request that Euromoney rectify any errors in the personal data that we process. In some circumstances, you may also be able to ask for the erasure of personal data, and/or request that the processing of your personal data be restricted. You may also object to the processing of your personal data for sales or marketing purposes.
-
How to Exercise Your Rights
To exercise any of these rights, please contact us by post or email at the following addresses:
Euromoney Institutional Investor PLC
8 Bouverie Street
London, EC4Y 8AX
United KingdomEmail: dataprotectionofficer@euromoneyplc.com
Web form: Complete Subject Data Request Form
We may need to check your identity prior to processing a request.
Euromoney will do our best to respond to any questions and address any of your concerns. You are also able to register any complaints regarding the processing of your personal data directly with the UK Information Commissioner.
Euromoney is committed to keeping your personal data secure and we will take appropriate technical and organisational measures to protect your personal data from loss, unauthorised use, disclosure or destruction. Although we do our best to protect your personal data, we cannot guarantee that any transmission of data is without risk. We have therefore implemented information security policies and rules, staff training on information security, and technical measures to ensure the integrity of data that we have under our control.
All our employees, contractors and data processors (i.e. those third parties that process personal data on our behalf) are required to keep such data confidential and not to use it for any purpose other than the performance of services we have requested.
Our site may contain links to other websites – including, for example, providers of payment processing services. Euromoney is not responsible for the privacy and data collection practices of third party sites and we therefore recommend that you review the privacy policies and terms of service of each site you visit.
email already exists, please use "Forgot Password" page to reset a password for an existing account.
(Click "Reset Password" button below and email with password reset instruction will be emailed to you.)